Chronic Obstructive Pulmonary Disease
1,716
103
138
1,075
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Published Results
233 trials with published results (14%)
Research Maturity
1075 completed trials (63% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
6.4%
110 terminated out of 1716 trials
90.7%
+4.2% vs benchmark
17%
300 trials in Phase 3/4
22%
233 of 1075 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1075 completed trials
Clinical Trials (1716)
A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
Study of Dehydroepiandrosterone (DHEA) in Respiratory Pulmonary Hypertension in Adults (DHEA-HTAP)
Titrated Ambulatory Oxygen in Fibrotic ILD and COPD With Isolated Exertional Hypoxemia
Study of Dehydroepiandrosterone (DHEA) in Respiratory Pulmonary Hypertension in Adults
A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD
Long-term Safety and Tolerability of Tozorakimab in Patients With COPD and History of Exacerbations
Role of Fibrocytes in the Bronchial Remodelling of Chronic Obstructive Pulmonary Disease
Role of Fibrocytes in Chronic Obstructive Pulmonary Disease
A Clinical Trial Comparing TQC3927 Inhaled Powder With Glycopyrronium Bromide and Formoterol Inhaled Aerosol (Biovoping® Lingchang®) for the Treatment of Chronic Obstructive Pulmonary Disease
A Study to Evaluate the Efficacy and Safety of RSS0343 Tablets in Patients With Chronic Obstructive Pulmonary Disease
Improving Participation in Pulmonary Rehabilitation Through Peer Support and Storytelling
The Effect of Inhaled Nitric Oxide on Pulmonary Gas-exchange in COPD
Oral Sildenafil for Exercise Capacity, Dyspnea and Cardiopulmonary Function in COPD
Investigating Health Related Quality of Life in Patients With Chronic Respiratory Failure
A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease
The Cardiovascular Consequences of Sleep Apnea Plus COPD (Overlap Syndrome)
A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)
A Study to Investigate the Effect of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Compared With Placebo MDI on Heart and Lung Function in Participants With Chronic Obstructive Pulmonary Disease (COPD) and Hyperinflation
COPD Care Pathway Among Patients With Cancer
A Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Study in Subjects With COPD